Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

OxyElite Pro Lawsuits Due To Alleged Liver Failure, Liver Damage Or Liver Problems From Recalled Supplements Being Reviewed by Wright & Schulte LLC
  • USA - English


News provided by

Wright & Schulte LLC

Nov 12, 2013, 15:50 ET

Share this article

Share toX

Share this article

Share toX

If you've suffered OxyElite liver failure, non-viral Hepatitis or other OxyElite side-effects contact Wright & Schulte LLC for a free case evaluation at 1-800-399-0795 or visit www.yourlegalhelp.com.
If you've suffered OxyElite liver failure, non-viral Hepatitis or other OxyElite side-effects contact Wright & Schulte LLC for a free case evaluation at 1-800-399-0795 or visit www.yourlegalhelp.com.

If you have experienced OxyElite side-effects please contact Wright & Schulte LLC today at 1-800-399-0795 or at www.yourlegalhelp.com for a free case evaluation.

Post this

Chicago, IL (PRWEB) November 12, 2013 -- Wright & Schulte LLC, an experienced harmful drug law firm representing individuals injured by defective drugs and dietary supplements, is now investigating OxyElite Pro side effect lawsuits on behalf of consumers who suffered severe liver injuries, including liver failure, liver damage, liver problems and non-viral hepatitis, allegedly due to OxyElite Pro “fat-burner” dietary supplements. According to a posting on the U.S. Food & Drug Administration’s (FDA) website, all lots and sizes of OxyElite Pro have been recalled nationwide following reports of liver failure and other severe liver injuries, including some that required liver transplants and at least one death, among consumers who used OxyElite Pro.
(fda.gov/food/recallsoutbreaksemergencies/outbreaks/ucm370849.htm, FDA, November 9, 2013

OxyElite Pro Liver Failure, Liver Damage, And Hepatitus May Be Side Side Effects Reports FDA
According to the FDA, OxyElite Pro is a dietary supplement sold as a “super thermogenic fat burner” that purportedly enhances the fat burning and muscle building benefits of working out. According to the agency, at least 56 cases of severe liver injury, liver failure and acute non-viral hepatitis have been associated with use of the product. These cases included 22 hospitalizations, two patients who required liver transplants and one fatality.

OxyElite Pro Recall Notice
According to the OxyElite Pro recall notice, this dietary supplement contains Aegeline, a synthesized version of a natural extract from the Bael tree. In a Warning Letter dated October 11, 2013, the FDA informed USPlabs LLC, the manufacturer of the supplement, that OxyElite Pro was deemed to be adulterated, as Aegeline was a new dietary ingredient which lacks adequate information to provide reasonable assurance of safety. The FDA letter also informed the company that failure to immediately cease distribution of OxyElite Pro could result in enforcement action by the agency.
(fda.gov/iceci/enforcementactions/warningletters/2013/ucm371203.htm, FDA, October 11, 2013)

Just prior to USPlabs’ announcement of the OxyElite Pro recall, the FDA issued a second letter to the company dated November 6, 2013. According to the FDA, that letter informed USPlabs of findings indicating a link between the use of OxyElite Pro products and a number of liver illnesses. The letter also stated that if USPlabs did not initiate a voluntary OxyElite Pro recall, the FDA could by law order the company to immediately stop distributing the dietary supplements and immediately notify other parties to stop distributing them.
(fda.gov/food/recallsoutbreaksemergencies/outbreaks/ucm370849.htm, FDA, November 9, 2013)

The FDA has advised consumers to discontinue using any dietary supplement products labeled as OxyElite Pro. According to the OxyElite Pro recall notice, the product may be returned to the store where it was purchased for a refund. Anyone who used OxyElite Pro should seek medical attention if they experience possible symptoms of liver injury, including fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay colored bowel movements, joint pain, yellow eyes, and jaundice.
(fda.gov/Safety/Recalls/ucm374394.htm, FDA, November 9, 2013)

Products Included In OxyElite Pro Recall

OxyElite Pro Super Thermo capsules

             Two count capsules UPC #094922417275
            10 count capsules UPC #094922417251
            10 count capsules UPC #094922417268
            21 count capsules UPC #094922426604
            90 count capsules UPC #094922395573
            90 count capsules “Pink label” UPC #094922447906
            180 count capsules UPC #094922447852

OxyElite Pro Ultra-Intense Thermo capsules

            three count capsules UPC #094922447883
            three count capsules UPC #094922447876
            90 count capsules UPC #094922395627
            180 count capsules UPC #094922447869

OxyElite Pro Super Thermo Powder

            Fruit Punch 0.15 oz UPC #094922417237
            Fruit Punch 0.15 oz UPC #094922447517
            Fruit Punch 4.6 oz UPC #094922426369
            Fruit Punch 5 oz. UPC #094922447487
            Blue Raspberry 4.6 oz UPC #094922426376
            Grape Bubblegum 4.6 oz UPC #094922447500
             Green Apple 4.6 oz. UPC #094922426499
Filing An OxyElite Pro Side Effects lawsuit Due To liver injury or Damage, liver failure, or non-viral hepatitis
Wright & Schulte LLC is offering free OxyElite Pro lawsuit reviews to consumers who developed OxyElite Pro Liver Failure, OxyElite Pro Liver Damage, or OxyElite Pro Hepatitis that may be linked to the use of this supplement. To learn more, or to arrange for a free OxyElite Pro Liver Failure, OxyElite Pro Liver Damage, or OxyElite Pro Hepatitis legal consultation with an attorney at Wright & Schulte LLC, please visit yourlegalhelp.com.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free OxyElite Pro lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
"An Experienced Harmful Drug Law Firm"
1-800-399-0795
http://www.yourlegalhelp.com

Richard Schulte, Wright & Schulte LLC, http://www.yourlegalhelp.com, +1 1-800-399-0795, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.